Αποτελέσματα 1 έως 14 από 14
| Τύπος | Ημερομηνία | Τίτλος | Δημιουργός | Πλήρες κείμενο |
| 1993 | Suppression of Interleukin-2 and Interleukin-2 Receptor Biosynthesis by Gold Compounds in Invitro Activated Human Peripheral-Blood Mononuclear-Cells | Sfikakis, P. P.; Souliotis, Vassilis L.; Panayiotidis, P. P. | |
| 1995 | Molecular and Immunohistochemical Study of Class-I Growth-Factor Receptors in Squamous-Cell Lung Carcinomas | Gorgoulis, V.; Sfikakis, P. P.; Karameris, A.; Papastamatiou, H.; Trigidou, R.; Veslemes, M.; Σπαντίδος, Δημήτριος Α.; Sfikakis, P.; Jordanoglou, J. | |
| 1996 | Regulation of bcl-2 and fas expression in primary activation of human peripheral lymphocytes is not sensitive to dexamethasone or cyclosporin-A | Sfikakis, P. P.; Souliotis, Vassilis L.; Akbar, A. N.; Katsilambros, N.; Hoffbrand, V. A.; Panayiotidis, P. | |
| 1996 | Downregulation of interleukin-2 and alpha-chain interleukin-2 receptor biosynthesis by cisplatin in human peripheral lymphocytes | Sfikakis, P. P.; Souliotis, Vassilis L.; Katsilambros, N.; Markakis, K.; Vaiopoulos, G.; Tsokos, G. C.; Panayiotidis, P. | |
| 1998 | Effects of 2-chlorodeoxyadenosine and gold sodium thiomalate on human bcl-2 gene expression | Sfikakis, P. P.; Dimopoulos, M. A.; Souliotis, Vassilis L.; Charalambopoulos, D.; Mavrikakis, M.; Panayiotidis, P. | |
| 2002 | Aberrant expression of the costimulatory molecule CD40 ligand on monocytes from patients with systemic lupus erythematosus | Katsiari, C. G.; Liossis, S. N. C.; Souliotis, Vassilis L.; Dimopoulos, A. M.; Manoussakis, M. N.; Sfikakis, P. P. | |
| 2003 | Gene-specific formation and repair of DNA monoadducts and interstrand cross-links after therapeutic exposure to nitrogen mustards | Souliotis, Vassilis L.; Dimopoulos, M. A.; Sfikakis, P. P. | |
| 2003 | Individual DNA damage and repair following exposure to melphaian are inversely associated with clinical outcome in patients with multiple myeloma treated with high dose melphalan and autologous blood stem cell transplantation | Dimopoulos, M. A.; Sfikakis, P. P.; Anagnostopoulos, A.; Hamilos, G.; Papadimitriou, C.; Souliotis, Vassilis L. | |
| 2004 | Intra- and intercellular variations in the repair efficiency of O-6-methylguanine, and their contribution to kinetic complexity | Souliotis, Vassilis L.; Sfikakis, P. P.; Anderson, L. M.; Kyrtopoulos, Soterios A. | |
| 2005 | Measurement of individual p53-specific damage formation and repair following in vitro exposure of peripheral mononuclear cells to melphalan may predict clinical outcome in patients with multiple myeloma (MM) subsequently treated with high dose melphalan (HDM) and autologous blood stem cell transplantation (ASCT) | Dimopoulos, M. A.; Souliotis, Vassilis L.; Anagnostopoulos, A.; Pouli, A.; Baltadakis, I.; Terpos, E.; Sfikakis, P. P. | |
| 2005 | Extent of damage and repair in the p53 tumor-suppressor gene after treatment of myeloma patients with high-dose melphalan and autologous blood stem-cell transplantation is individualized and may predict clinical outcome | Dimopoulos, M. A.; Souliotis, Vassilis L.; Anagnostopoulos, A.; Papadimitriou, C.; Sfikakis, P. P. | |
| 2006 | Preferential in vivo DNA repair of melphalan-induced damage in human genes is greatly affected by the local chromatin structure | Souliotis, Vassilis L.; Dimopoulos, M. A.; Episkopou, H. G.; Kyrtopoulos, Soterios A.; Sfikakis, P. P. | |
| 2006 | Melphalan-induced DNA damage in vitro as predictor for clinical outcome in multiple myeloma | Dimopoulos, M. A.; Souliotis, Vassilis L.; Anagnostopoulos, A.; Bamia, C.; Pouli, A.; Baltadakis, I.; Terpos, E.; Kyrtopoulos, Soterios A.; Sfikakis, P. P. | |
| 2007 | Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis | Sfikakis, P. P.; Souliotis, Vassilis L.; Fragiadaki, K. G.; Moutsopoulos, H. M.; Boletis, J. N.; Theofilopoulos, A. N. | |
